Report Highlights
CDMO is an evolving industry with abundant growth opportunities for service providers. CDMO industry is trending towards consolidation; thus, CDMO companies are evolving as integrated pharmaceutical service providers or one-stop solution providers. This report provides details on the CDMO industry including the future trends and latest developments.
Report Includes
- Descriptive overview of the global pharmaceutical contract development and manufacturing organization (CDMO) market within the industry
- Analyses of the global market trends, with data corresponding to market size for 2019, estimates for 2020, and projections of compound annual growth rates (CAGRs) through 2025
- Discussion of the market potential and opportunities for pharmaceutical CDMO, current trends and future prospects, regulatory updates, and other macroeconomic factors shaping global marketplace
- Identification of the pharma companies that are considered as leaders in their field, as well as technological means these companies are using to exploit their markets and dominate the market in their fields
- Competitive landscape of the global CDMO market featuring companies with potential profitability in contracting with a CMO (contract manufacturing outsourcing) for both clinical and commercial stage manufacturing, and market share analysis of the top 20 CDMO companies
- Profile description of the major pharmaceutical companies
Report Scope
This report provides an overview of the pharmaceutical industry and the role contract development and manufacturing organizations (CDMO) play in it. This analysis includes a review of the global CDMO market by-service type, drug molecule type and end use. This report limits the CDMO market landscape to the US and European regions, and analyzes their regulatory policies, standards and inspection trends. The report also analyzes the competitive landscape, key competitors, key leaders, and the CDMO industry's top 20 manufacturers.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets (HLC176E)
- Carbon Credits Market: Global Outlook (EGY200A)
- Drugs and Diagnostics for Hematological Disorders: Global Markets (PHM116C)
- Global Flame and Smoke Detectors Markets (MFG092A)
- Biodegradable Polymers: Global Markets and Technologies (PLS025K)
Related Reports
Biologics Contract Development and Manufacturing Organizations (CDMOs): Global Markets
The global market for biologics CDMOs is expected to increase from $15.1 billion in 2023 to $27.0 billion by the end of 2028, with a compound annual growth rate (CAGR) of 12.3% during the forecast period of 2023-2028.
Global MedTech Healthcare IT Industry Competitive Landscape
This report discusses the MedTech market and industry competitive landscape in terms of major player market ranking and future of medical technology. Regulatory framework for medical devices, competitive intelligence and market trends are well-researched and analyzed in this report.
Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging
The global market for contract pharmaceutical manufacturing, research and packaging services should grow from $168.0 billion in 2021 to $214.7 billion by 2026, at a compound annual growth rate (CAGR) of 5.0% during the forecast period of 2021-2026.
Contract Manufacturing: Global Markets to 2023
The global market for contract manufacturing should grow from $2.0 trillion in 2018 to $2.7 trillion in 2023 with a compound annual growth rate (CAGR) of 6.6% from 2018 through 2023.
Recent Reports
Drugs and Diagnostics for Hematological Disorders: Global Markets
The global market for drugs and diagnostics for hematological disorders is expected to grow from $131.2 billion in 2024 and is projected to reach $189.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.6% during the forecast period of 2024 to 2029.
Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets
The global market for gastrointestinal (GI) therapeutics and diagnostics is expected to grow from $86.0 billion in 2023 and projected to reach $122.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.3% during the forecast period of 2023 to 2028.
Global Markets and Technologies for Advanced Drug Delivery Systems
The global market for advanced drug delivery systems is expected to increase from $262.6 billion in 2023 to $359.1 billion by the end of 2028, with a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2023-2028.
Prevention and Treatment of Prostate Cancer: Technologies and Global Markets
The global market for prostate cancer care is expected to grow from $37.9 billion in 2023 to $56.4 billion by the end of 2028, at a compound annual growth rate (CAGR) of 8.3% from 2023 through 2028.
Chagas Disease: American trypanosomiasis Market
The report provides detailed coverage of the Chagas Disease market. It analyzes the market trends and epidemiology of CD, and the regional markets of CD. It highlights the current market for CD and gives a detailed analysis of the competitive environment. The report depicts the complete scenario of Chagas Disease, types of parasites that cause human African trypanosomiasis (HAT) and its presence in various regions of the world.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More